Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

26.33p
   
  • Change Today:
    -0.17p
  • 52 Week High: 67.50
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 125.28m
  • Volume: 54,549
  • Market Cap: £32.99m
  • RiskGrade: 594

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 15.7  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Company Announcements

Notice of AGM, Annual Report and Accounts 27-Nov-2024 09:38 RNS
Final Results for the Year Ended 30 June 2024 29-Oct-2024 07:00 RNS
Notice of Final Results and Investor Presentation 23-Oct-2024 07:00 RNS

Sareum Holdings ShareCast News

Sareum shares rise on China patent allowance 16-Sep-2024 ShareCast
Sareum announces positive results from kinase in... 01-Jul-2024 ShareCast
Sareum allowed European patent for primary kinas... 15-Mar-2024 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 26.33p
Change Today -0.17p
% Change -0.63 %
52 Week High 67.50
52 Week Low 10.25
Volume 54,549
Shares Issued 125.28m
Market Cap £32.99m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.32% below the market average52.32% below the market average52.32% below the market average52.32% below the market average52.32% below the market average
8% below the sector average8% below the sector average8% below the sector average8% below the sector average8% below the sector average
Price Trend
83.45% below the market average83.45% below the market average83.45% below the market average83.45% below the market average83.45% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 10-Dec-2024

Time Volume / Share Price
08:43 1,858 @ 26.90p
08:43 7,412 @ 26.90p
08:42 833 @ 26.20p
08:37 5,000 @ 26.20p
08:07 21,984 @ 26.49p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page